GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrobiosystems Co Ltd (SZSE:301080) » Definitions » COGS-to-Revenue

Acrobiosystems Co (SZSE:301080) COGS-to-Revenue : 0.07 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acrobiosystems Co COGS-to-Revenue?

Acrobiosystems Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥10.8 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥146.0 Mil.

Acrobiosystems Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.07.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Acrobiosystems Co's Gross Margin % for the three months ended in Mar. 2024 was 92.58%.


Acrobiosystems Co COGS-to-Revenue Historical Data

The historical data trend for Acrobiosystems Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrobiosystems Co COGS-to-Revenue Chart

Acrobiosystems Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial 0.12 0.08 0.07 0.07 0.09

Acrobiosystems Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.09 0.08 0.09 0.07

Acrobiosystems Co COGS-to-Revenue Calculation

Acrobiosystems Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=47.488 / 543.653
=0.09

Acrobiosystems Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=10.828 / 145.999
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acrobiosystems Co  (SZSE:301080) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Acrobiosystems Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 10.828 / 145.999
=92.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Acrobiosystems Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Acrobiosystems Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Acrobiosystems Co (SZSE:301080) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Hongda North Road, 4th Floor, Building 4, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.

Acrobiosystems Co (SZSE:301080) Headlines

No Headlines